Skip to content

Warning over atazanavir and Prilosec, other acid control drugs too

HIVNET 012 controversy puts ART programmes at risk

NNRTIs more forgiving for occasionally forgetful patients; but are they the best option for patients with major adherence issues?

CD4 counts, not viral load, associated with changes in weight on HAART

Health consequences of sexual behaviour examined in US study

TB diagnosis in children can be improved with new test

Herpes zoster remains common in HIV-positive women in HAART era

Risk of TB doubles in first year of HIV infection

HIV's impact on TB control: is it time to re-think TB control strategies?

In HAART patients with nausea, marijuana use does not lead to poor adherence

Rationing of treatment inevitable, explicit criteria need open debate

HIV-positive HAART treated women in US show similar body fat change pattern to men

Micronutrient supplement increases vaginal shedding of HIV, finds study

Efforts needed to improve diagnosis of primary HIV infection to control spread, say UK researchers

Simple sputum test for confirmation of childhood tuberculosis

Treatment failure, not transmission, will be main source of drug resistant HIV in Africa in next 10 years

Prevention investment needed now to ensure long-term affordability of treatment

Low rate of treatment failure with tenofovir, 3TC and AZT